1. Canada Stocks

  2. •

    Health technology

  3. •

    Medical specialties
AVITAR INC

AVITAR INC

OOTC:AVTI
0.00
USD
0.00
(0.00%)
-0.04EPS
431,713.25Market Cap
AVITAR INC
OTC:AVTI
(OTC Markets)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
TTM
USD
41.93
4.25
7.27
4.94
6.64
10.3
11.68
3.64
1.9
1.54
0.93
0.16
0.06
Revenue per Share
-13.78
-35.5
-2.5
-6.13
-10.36
-10.19
-5.5
-5.11
-1.13
-0.83
-0.8
-0.12
-0.06
Basic EPS, GAAP
-9.12
-7.88
-4.87
-6.72
-10.37
-7.74
-4.66
-1.95
-1.76
-1.44
-0.58
-0.09
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
Dividend per Share
27.66
-4.28
-4.1
4.94
4.2
2.83
0.13
-0.93
-0.28
-1.29
-1.33
-0.22
-0.11
Book Value per Share
-1.95
-4.28
-4.1
-0.4
- -
-0.55
-2.27
-1.06
-0.38
-1.32
-1.33
-0.22
-0.11
Tangible Book Value per Share
- -
- -
- -
1
1
1
1
1
2
3
5
20
45
Basic Weighted Avg Shares
5
1
2
3
4
7
10
5
4
5
5
3
3
Sales/Revenue/Turnover
-29.57
-818.63
-81.36
-128
-155.79
-92.35
-43.64
-69.66
-64.97
-84.89
-64.02
-87.98
-106.51
Operating Margin (%)
1
1
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
Depreciation Expense
-2
-8
-1
-3
-6
-6
-4
-6
-2
-2
-4
-2
-3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-32.87
-834.68
-34.4
-124
-155.94
-93.07
-43.11
-140.54
-59.57
-53.96
-81.95
-72.75
-97.99
Profit Margin (%)
- -
-2
-2
-1
-1
-1
-1
-1
- -
-1
-3
-4
-5
Working Capital
- -
- -
- -
- -
- -
- -
1
1
- -
1
3
4
4
LT Debt
5
-1
-1
3
2
2
- -
-2
-1
-5
-8
-10
-11
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
-256.13
-286.53
-418.41
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Jun'07
Sep'07
Dec'08
ST Debt
1
1
2
LT Borrowings
4
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
46
103
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Jun'07
Sep'07
Dec'08
Total Current Assets
1
1
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
4
4
5
Payables & Accruals
2
2
2
ST Debt
1
1
2
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-105.59%
-135.59%
20.31%
Free Cash Flow
11.7%
-8.13%
-36.42%
Net Income, GAAP
29.5%
1.46%
-38.98%
Sales/Revenue/Turnover
23.49%
-16.76%
-31.26%
Total Cash Common Dividend
- -
- -
5.74%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
1
1
1
1
5
2007
1
1
1
1
3
2008
1
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
-0.22
-0.24
-0.3
-0.05
-0.8
2007
-0.08
-0.05
0.01
-0.01
-0.12
2008
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Avitar, Inc. (AVTI) develops, manufactures, and markets diagnostic test products and medical disposables through its wholly owned subsidiary Avitar Technologies, Inc.; core offerings include ORALscreen 4 and ORALscreen DRUGOMETER, oral fluid-based onsite assay systems for detecting drugs of abuse such as opiates (heroin, morphine, codeine, oxycodone, hydrocodone), cocaine, marijuana, and methamphetamines (meth, ecstasy); foam disposable products comprising medical-grade hydrophilic polyurethane foam items like Hydrasorb wound dressings for exudating wounds, sinus dressings, and custom foam devices including those for astronaut ear pressure relief in space suits; and additional specialty products such as wound dressings for cardiac catheter labs and Illizarov dressings for orthopedic external bone fixators. The company, founded in 1986, is headquartered in Canton, Massachusetts, with an additional office in Calgary, Canada, and operates primarily in the healthcare supplies industry, serving employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales, strategic partners, and distributors. Avitar functions as a holding company that also pursues investments and joint ventures across various fields; no major acquisitions, funding rounds, partnerships, or strategic expansions have been publicly reported in the last 1-2 years, with the firm maintaining a low market capitalization of approximately $731 amid stagnant growth forecasts.

Company News

Company News APIChatGPT

  • defenseworld.net

    Head to Head Contrast: Avitar (OTCMKTS:AVTI) and Becton, Dickinson and Company (NYSE:BDX)

  • defenseworld.net

    Critical Survey: Becton, Dickinson and Company (NYSE:BDX) and Avitar (OTCMKTS:AVTI)